Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • WMB vs MRNA✓SelectedUSD · MRNAWMB vs MRNA performance historyLatest closeAs of-2.14%11/16
Stock and ETF performance explorer

WMB vs MRNA

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+198.5%
MRNA return
-8.0%
Excess return
+206.5%
Maximum drawdown
-23.0%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 5y.

Portfolio and benchmark returns by period
PeriodPortfolioMRNAExcessAlpha
1D-2.1%-3.6%+1.5%-2.1%
7D+1.7%-20.0%+21.7%+1.7%
30D-5.1%-1.3%-3.9%-5.1%
3M-9.4%+240.0%-249.4%-9.6%
6M-11.7%+339.0%-350.7%-12.7%
YTD+15.0%+630.0%-615.0%+11.2%
1Y+14.2%+769.1%-754.8%+9.7%
3Y+117.7%+181.2%-63.6%+113.7%
5Y+198.5%-8.1%+206.6%+195.7%
All+198.5%-8.0%+206.5%+195.7%

Cumulative growth

Daily Returns

Daily percentage return beside MRNA.

Daily Out/Under-Performance

Portfolio return minus MRNA return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

5y analysis · Full analysis span regression · 6 months rolling